Inhibition of VEGF-R2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function

被引：0
|
作者：
Villalta, S. [1 ]
Lang, Jiena [1 ]
Kubeck, Samantha [1 ]
Kabre, Beniwende [1 ]
Szot, Gregory [1 ]
Calderon, Boris [2 ]
Brekken, Rolf [3 ]
Pullen, Nick [5 ]
Arch, Robert [4 ]
Bluestone, Jeffery [1 ]
机构：
[1] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA
[2] Washington Univ, Dept Pathol & Immunol, Dallas, MO USA
[3] UT Southwestern Med Ctr, Div Surg Oncol, Dallas, TX USA
[4] Pfizer Inc, Pfizer Global Res & Dev, Chesterfield, MO USA
[5] Pfizer Inc, Pfizer Global Res & Dev, Cambridge, MA USA
来源：
JOURNAL OF IMMUNOLOGY | 2013年 / 190卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P5181
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Anti-TCRβ mAb in Combination With Neurogenin3 Gene Therapy Reverses Established Overt Type 1 Diabetes in Female NOD Mice
    Xie, Aini
    Li, Rongying
    Jiang, Tao
    Yan, Hui
    Zhang, Hedong
    Yang, Yisheng
    Yang, Lina
    Yechoor, Vijay
    Chan, Lawrence
    Chen, Wenhao
    ENDOCRINOLOGY, 2017, 158 (10) : 3140 - 3151
  • [42] Inhibition of Deoxyhypusine Synthase Enhances Islet β Cell Function and Survival in the Setting of Endoplasmic Reticulum Stress and Type 2 Diabetes
    Robbins, Reiesha D.
    Tersey, Sarah A.
    Ogihara, Takeshi
    Gupta, Dhananjay
    Farb, Thomas B.
    Ficorilli, James
    Bokvist, Krister
    Maier, Bernhard
    Mirmira, Raghavendra G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (51) : 39943 - 39952
  • [43] Proinsulin 2 knockout NOD mice -: A model for genetic variation of insulin gene expression in type 1 diabetes
    Dubois-Lafforgue, D
    Mogenet, L
    Thébault, K
    Jami, J
    Krief, P
    Boitard, C
    DIABETES, 2002, 51 : S489 - S493
  • [44] miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes
    Ventriglia, Giuliana
    Mancarella, Francesca
    Sebastiani, Guido
    Cook, Dana P.
    Mallone, Roberto
    Mathieu, Chantal
    Gysemans, Conny
    Dotta, Francesco
    DIABETOLOGIA, 2020, 63 (01) : 124 - 136
  • [45] miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes
    Giuliana Ventriglia
    Francesca Mancarella
    Guido Sebastiani
    Dana P. Cook
    Roberto Mallone
    Chantal Mathieu
    Conny Gysemans
    Francesco Dotta
    Diabetologia, 2020, 63 : 124 - 136
  • [46] Long-term Reversal of Hyperglycemia in Experimental Type 1 Diabetes in NOD Mice by Inhibition of Smad7 with an Antisense Oligonucleotide
    Cechin, Sirlene R.
    Lopez-Ocejo, Omar
    Ricordi, Camillo
    Buchwald, Peter
    DIABETES, 2014, 63 : A426 - A426
  • [47] Gene Therapy for Type 1 Diabetes: A Combinatorial Approach Using Neurogenin-3-Interleukin-10 Hepatic Gene Transfer Reverses Diabetes in Overtly Diabetic NOD Mice.
    Ozer, K.
    Yechoor, V.
    Buras, E.
    Liu, V.
    Chan, L.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [48] INHIBITION OF TYPE I DIABETES IN FILARIA INFECTED NOD MICE IS ASSOCIATED WITH A TH2 SHIFT AND INDUCTION OF REGULATORY T CELLS
    Huebner, Marc R.
    Torrero, Marina N.
    Larson, David
    Stocker, J. Thomas
    Mitre, Edward
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 79 (06): : 231 - 232
  • [49] BTNL2-Ig Protein Attenuates Type 1 Diabetes in Non-Obese Diabetic (NOD) Mice
    Tian, Xiaohong
    Lin, Yujun
    Cui, Cheng
    Su, Min
    Lai, Laijun
    ADVANCED HEALTHCARE MATERIALS, 2019, 8 (09)
  • [50] A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice
    Lin, Ming S.
    Tse, Hubert M.
    Delmastro, Meghan M.
    Bertera, Suzanne
    Wong, Caterina T.
    Lakomy, Robert
    He, Jing
    Sklavos, Martha M.
    Coudriet, Gina M.
    Pietropaolo, Massimo
    Trucco, Massimo M.
    Piganelli, Jon D.
    IMMUNOLOGIC RESEARCH, 2011, 50 (2-3) : 213 - 220
12345